This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.
Natalie Boytsov, PhD
Advertisement
Articles by Natalie Boytsov, PhD
We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Advertisement
Latest Updated Articles
- Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare Resources
Published: February 26th 2015 | Updated:
- Daily Dose and Costs of Therapy With Topical Testosterone Agents
Published: December 16th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
FDA Grants Orphan Drug Status to Immunotherapy for Acute Myeloid Leukemia Treatment
5
